GlassScriptPhysician profile
Elliot N Michael
NPI 1679682439
$5,067.36
in general payments reported to CMS, 2019-2025
22 companies · $893 in 2025
The $893 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $103 · 2021: $360 · 2022: $1,767 · 2023: $462 · 2024: $854 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,208.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $1,562.37 | 2019-2024 | |
| Smith+Nephew, INC. | $1,006.28 | 2019-2025 | Evos, Evos Mini, Stravix Pl |
| Depuy Synthes Sales INC. | $595.72 | 2019-2025 | Va-Lcp, Motoband |
| Zimmer Biomet Holdings, INC. | $376.98 | 2019-2024 | Xtrafix, A.L.P.S. |
| Paragon 28, INC. | $192.54 | 2019-2022 | |
| Integra Lifesciences Corporation | $189.90 | 2019-2025 | Tcc-Ez |
| Stryker Corporation | $155.56 | 2020-2021 | |
| Linvatec Corporation | $118.34 | 2024 | Biobrace 23mm |
| Next Science LLC | $109.62 | 2023 | Surgx, Blastx, Xperience |
| Orthofix Medical, INC. | $108.59 | 2023 | Physio-Stim |
| Mimedx Group, INC. | $102.18 | 2025 | |
| Koya Medical, INC. | $99.75 | 2025 | Koya Medical, Dayspring |
| Globus Medical, INC. | $89.41 | 2025 | Senza |
| Lifenet Health | $78.91 | 2024 | Lateral Ankle |
| Bard Peripheral Vascular, INC. | $68.96 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $59.41 | 2022 | |
| Medtronic, INC. | $48.16 | 2023 | Venaseal |
| Nevro Corp. | $33.29 | 2024 | Senza |
| Solventum Corporation | $21.09 | 2025 | Activ.A.C. |
| Tactile Systems Technology INC | $20.75 | 2024 | Flexitouch Plus, Entre Plus |
| Arteriocyte Medical Systems, INC. | $15.42 | 2022 | |
| Horizon Therapeutics Plc | $14.13 | 2023 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliot Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.